beam me up scottieBuy $4 dollar stock. Sell $7 or $12. place Stop loss 0.50c below the dashed-line for your protection. Live-Laugh-Love. Let's make 2024 great.Longby sofearnotUpdated 224
BVS: Bioventus – Innovations and Growth in Medical TechnologiesBioventus Inc. (Nasdaq:BVS) , a company specializing in medical devices and active treatments, has demonstrated significant achievements despite challenges. Recent research and company decisions indicate potential for further growth and innovations in the healthcare sector. The company recently reported financial results for the third quarter of 2023, confirming its ability to manage costs and increase efficiency. Improved performance in pain treatment and ongoing cost management contributed to an upgraded financial forecast for the full fiscal year. Despite a decrease in net sales, the company's results exceeded expectations, allowing it to raise the financial forecast for the entire year. Bioventus is also actively working on reducing debt and optimizing its cost structure. Recent appointments to senior management, including new President and CEO Robert Klai, with more than two decades of experience in medical devices, underline the company's commitment to improving operational efficiency and revenue growth. Furthermore, Bioventus secured a nationwide contract with Aetna™ Medicare Advantage plans for DUROLANE®, used in knee osteoarthritis treatment, reflecting recognition of their products' effectiveness and market expansion. For investors looking for opportunities in the healthcare sector, BVS shares offer a unique balance of innovation, growth, and strategic focus on financial performance improvement. With a strong management team, strategic partnerships, and growth potential in medical technologies, Bioventus represents an attractive investment opportunity. NOT TRADING ADVICE. ALWAYS DO YOUR OWN RESEARCH.Longby olimchik0
$BVS: Bioventus is a $45 TargetI believe the price target for Bioventus can easily be $45. It is a new IPO for a company w/ 700+ employees, disruptive orthobiologics and surgical methods, and high growth potential. Support just needs to pickup. That said, please do your own due diligence and invest at your own risk. Everything I say is on an opinion based basis.Longby gamer4561481
$BVS is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea Bioventus is a global medical device company focused on developing and commercializing clinically differentiated, cost efficient and minimally invasive treatments that engage and enhance the body’s natural healing process. The share price is rising and gonna continue this trend today. The demand for shares of the company still looks higher than the supply. These and other conditions can cause a rise in the share price today. So I opened a long position from $17,00; stop-loss — $14,00; take-profit — 26,00/MOC price. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas.Longby KozakHlib2